Hopman Mark's Form 4/A amendment
AmendedBeta Bionics, Inc. (BBNX) · filed Sep 18, 2026
- Accession no.
- 0002048497-26-000016
- Filed
- Sep 18, 2026, 7:51 PM ET
- Trade date
- Sep 9, 2026
- Filing delay
- 9 days
- Rule 10b5-1 plan
- Checked
- Original filed
- Sep 10, 2026
This filing lists 1 non-derivative transaction. Open-market sales total $664.6K. It was filed 9 days after the trade.
This amendment replaces 0002048497-26-000013 (filed Sep 10, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hopman MarkCIK 0002048497 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Common Stock | SSaleDisposed | −35,994 | $18.46 | −$664,550.02 | 88,033 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026 (the "10b5-1 Plan").
- F2
On September 10, 2026, the reporting person filed a Form 4 which incorrectly reported the number of shares disposed. The reporting person sold 35,994 shares under the 10b5-1 Plan on September 9, 2026 and the number of securities beneficially owned following the sale was 88,033 shares.